珍宝岛: 黑龙江珍宝岛药业股份有限公司2025年半年度业绩预告的公告

Group 1 - The company expects a net profit attributable to shareholders of approximately -77 million to -66 million yuan for the first half of 2025, indicating a loss compared to the same period last year [1][2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is approximately -83 million to -73 million yuan [1][2] - The performance forecast period is from January 1, 2025, to June 30, 2025, and the forecast is based on preliminary calculations by the company's financial department, not yet audited by certified public accountants [1][2] Group 2 - In the same period last year, the total profit was 501.67 million yuan, with a net profit attributable to shareholders of 393.33 million yuan and a net profit of 362.12 million yuan after deducting non-recurring gains and losses [2] - The primary reason for the expected loss is a decrease in product prices, leading to a 57% year-on-year decline in revenue and a 64% year-on-year decline in gross profit [2]